Clinical Trial Update: A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating diabetes outcomes in kidney transplant recipients on immunosuppressive regimens with or without steroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• PREDNISONE (Prednisone)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED